Literature DB >> 14284381

INHIBITION OF LANDSCHUETZ ASCITES TUMOUR GROWTH BY METAL CHELATES DERIVED FROM 3,4,7,8-TETRAMETHYL-1,10-PHENANTHROLINE.

F P DWYER, E MAYHEW, E M ROE, A SHULMAN.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS; COPPER; EXPERIMENTAL LAB STUDY; MICE; NEOPLASMS, EXPERIMENTAL; PHARMACOLOGY; PHENANTHROLINES; RUTHENIUM

Mesh：

Substances：

Year:  1965        PMID： 14284381      PMCID： PMC2071418          DOI： 10.1038/bjc.1965.24

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  3 in total

1.  ACTIONS OF METAL CHELATES OF SUBSTITUTED 1,10-PHENANTHROLINES ON VIRUSES AND CELLS. II. INHIBITION OF VIRAL MULTIPLICATION.

Authors:  D O WHITE; A W HARRIS; A SHULMAN
Journal:  Aust J Exp Biol Med Sci       Date:  1963-10

2.  Anti-tumour activities of copper chelates.

Authors:  K TAKAMIYA
Journal:  Nature       Date:  1960-01-16       Impact factor: 49.962

3.  Influence of metallic chelates on the diphosphopyridine nucleotide oxidase and diphosphopyridine nucleotide-cytochrome c reductase systems.

Authors:  P LENTA; A RIEHL
Journal:  J Biol Chem       Date:  1960-03       Impact factor: 5.157
  3 in total
  7 in total

1.  A newly synthesized molecule derived from ruthenium cation, with antitumour activity, activates NADPH oxidase in human neutrophils.

Authors:  M Carballo; R Vilaplana; G Márquez; M Conde; F J Bedoya; F González-Vílchez; F Sobrino
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

Review 2.  An Overview of Coumarin as a Versatile and Readily Accessible Scaffold with Broad-Ranging Biological Activities.

Authors:  Francesca Annunziata; Cecilia Pinna; Sabrina Dallavalle; Lucia Tamborini; Andrea Pinto
Journal:  Int J Mol Sci       Date:  2020-06-29       Impact factor: 5.923

3.  Biological Investigations of Ru(II) Complexes With Diverse β-diketone Ligands.

Authors:  Raphael T Ryan; Dmytro Havrylyuk; Kimberly C Stevens; L Henry Moore; Sean Parkin; Jessica S Blackburn; David K Heidary; John P Selegue; Edith C Glazer
Journal:  Eur J Inorg Chem       Date:  2021-07-21       Impact factor: 2.551

4.  Tetramethyl-phenanthroline copper complexes in the development of drugs to treat cancer: synthesis, characterization and cytotoxicity studies of a series of copper(II)-L-dipeptide-3,4,7,8-tetramethyl-phenanthroline complexes.

Authors:  Natalia Alvarez; Celisnolia M Leite; Adriana Napoleone; Luis F S Mendes; Carlos Y Fernández; Ronny R Ribeiro; Javier Ellena; Alzir A Batista; Antonio J Costa-Filho; Gianella Facchin
Journal:  J Biol Inorg Chem       Date:  2022-05-07       Impact factor: 3.862

5.  Regression of lung cancer by hypoxia-sensitizing ruthenium polypyridyl complexes.

Authors:  Abhishek Yadav; Thamara Janaratne; Arthi Krishnan; Sharad S Singhal; Sushma Yadav; Adam S Dayoub; Doyle L Hawkins; Sanjay Awasthi; Frederick M MacDonnell
Journal:  Mol Cancer Ther       Date:  2013-02-26       Impact factor: 6.261

6.  Cellular and cell-free studies of catalytic DNA cleavage by ruthenium polypyridyl complexes containing redox-active intercalating ligands.

Authors:  Cynthia Griffith; Adam S Dayoub; Thamara Jaranatne; Nagham Alatrash; Ali Mohamedi; Kenneth Abayan; Zachary S Breitbach; Daniel W Armstrong; Frederick M MacDonnell
Journal:  Chem Sci       Date:  2017-03-08       Impact factor: 9.825

Review 7.  Ruthenium Complexes in the Fight against Pathogenic Microorganisms. An Extensive Review.

Authors:  Alexandra-Cristina Munteanu; Valentina Uivarosi
Journal:  Pharmaceutics       Date:  2021-06-13       Impact factor: 6.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.